Assessment of Progressive Lens Designs

NCT ID: NCT04734522

Last Updated: 2021-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-19

Study Completion Date

2021-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-invasive double-blind randomised comparative study on presbyopic subjects wearing progressive lenses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background and rationale:

Nowadays many different types of progressive addition lenses are available for the correction of presbyopia. Progressive addition lenses provide a more natural correction for presbyopic people due to a gradual and progressive increase of lens power from far area through the intermediate portion to the near area. However, some patients still experience adaptation problems.

The primary purpose of the study is to evaluate the preference, adaptability and visual performance of progressive lens designs (up to three designs).

Study procedures:

Each participant is required to wear all pairs of spectacles one after another, each pair for one week.

Each participant will be required to visit the optometry clinic (at University of Milano Bicocca) three times:

Visit #1: Screening based on inclusion criteria, Informed Consent Form (ICF) form signing, Optometric exam and choice of the frame.

Subjects who will pass the inclusion/exclusion screening will be asked to sign the ICF and enrolled for the optometric exam. Subjects will choose the spectacle frame and all individual fitting parameters will be measured for lens' manufacturing.

Visit #2: Subjects will receive three marked pairs of progressive lenses. The three spectacle frames will be adjusted to fit properly on the subject' face. After 10-15 min of wearing of the first pair of lenses, each subject will be asked to answer to a questionnaire.

Visit #3 (last visit): questionnaires should be returned; the last comparison question will be answered during this visit, and subject will choose the best pair.

At the end of the study each participant will be entitled to get one pair of progressive lenses available in the market.

Subject population:

Presbyopic subjects have been already wearing any progressive additional lens (PAL) designs.

Number of Subjects:

40 +/- 2 subjects, the specified PAL design wearers and 40 +/- 2 the other PAL design wearers to be enrolled and signed the informed consent form.

Each subject will be wearing three different PAL designs. Subjects will be asked to choose one pair of spectacles (design) which they like the most.

Randomisation:

This study adopts a stratified permuted block randomisation to reduce an evaluation bias by the wearing sequence and prescriptions. The mean of both eyes' prescriptions is set as a single stratification factor.

Frames:

Each subject will choose a model of spectacle frame. Three identical frames will be taken for each subject.

Lenses:

1. Lenses will be produced in EU
2. Three different lens designs will be tested in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Presbyopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The specified PAL design wearers

Subjects who have been already wearing any from specified design type of PAL

Group Type EXPERIMENTAL

Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Intervention Type DEVICE

Subjects will be wearing three different PAL designs with different geometries of the optical progression.

The other PAL design wearers

Subjects who have been already wearing any from the other design type of PAL

Group Type ACTIVE_COMPARATOR

Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Intervention Type DEVICE

Subjects will be wearing three different PAL designs with different geometries of the optical progression.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Subjects will be wearing three different PAL designs with different geometries of the optical progression.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subjects should be experienced progressive lens designs wearers who have worn their current prescription for at least the last one month.
2. PAL wearers with 14 mm corridor
3. Age: 45 to 70 years old
4. Best Corrected Monocular visual Acuity (decimal) both at distance and near ≥ 1.0;
5. Normal binocular vision at distance \& near:

* no strabismus on cover test,
* no fixation disparity (Mallett aligning prism of less than 2Δ horizontally or vertically) at near
* stereoacuity of 60" or better at near;
6. New prescription (found at visit #1) is in the range:

* Spherical power: up to +/-6.00;
* Cylindrical power: minus cylinder ≤ 2.5D;
* Addition: 1.50-2.50D;
* Difference in the power (spherical equivalent) between eyes: up to 2.0D
7. Understanding and speaking Italian or English to be able to answer questionnaires
8. Giving a written consent to participate in the study

Exclusion Criteria

1. First prescription for progressive lenses.
2. Prescription found during visit#1 varies from current prescription more than 0.50D in any meridian
3. Wearing Single Vision lenses with accommodative support
4. Double vision or prismatic prescription in current glasses;
5. Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity
6. Use of systemic or ocular medications that are likely to affect vision
7. Balance problem/vertigo problem
8. Concurrent participation in other vision-related research
Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoya Vision Care

INDUSTRY

Sponsor Role collaborator

University of Milano Bicocca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Silvia Tavazzi

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Optics and Optometry of Milano-Bicocca (COMiB), Department of Materials Science - University of Milano-Bicocca

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multifocal Visual Performance Study
NCT03757039 TERMINATED NA